Le Lézard
Classified in: Health
Subjects: NPT, WOM

National Menopause Foundation Launches Women's Midlife Health Policy Institute (WMHPI)

WMHPI Seeks to Inspire Consensus and Action to Improve Women's Health at Midlife.

ALEXANDRIA, Va., Nov. 29, 2023 /PRNewswire/ -- The National Menopause Foundation is pleased to announce the launch of the Women's Midlife Health Policy Institute (WMHPI) to improve the health and wellbeing of women as they journey to and through menopause by advancing research, education, and policies related to women's health at midlife.

In the United States, approximately 1.3 million women become menopausal each year.1 By the year 2025, the number of postmenopausal women worldwide is expected to reach 1.1 billion.2

"Despite the prevalence and impact of menopause, there is a lack of research, education, and resources dedicated to addressing menopause-related health issues, and many women feel underserved and unsupported in navigating this life stage," said Claire Gill, founder and president, the National Menopause Foundation.  "The WMHPI will coordinate a collective policy agenda that amplifies the needs of women at midlife and targets united action among stakeholders to inspire policy that can have a systemic impact on improving women's health."

According to the Study of Women's Health Across the Nation (SWAN), which began in 1994, there are racial and ethnic differences with respect to menopausal symptoms and risk for diseases that impact women at a higher rate postmenopausal. Black women are more likely to report heavy bleeding, have hysterectomies, and have higher rates of vasomotor symptoms (VMS). Hispanic women develop metabolic syndrome, Type 2 Diabetes, anxiety, depression and VMS. Non-Hispanic Caucasian women have the greatest incident of low bone density.3

In order to gain alignment on needs and priorities, the WMHPI will bring leading women's health advocacy stakeholders, thought leaders, and clinicians together in the first quarter of 2024 in an inclusive and facilitated process to uncover opportunities for a shared policy agenda & action plan.  The WMHPI will create a white paper sharing focus and need areas to advance women's every day health at midlife and beyond.

For more information about menopause and the Women's Midlife Health Policy Institute visit www.nationalmenopausefoundation.org.

About the National Menopause Foundation

The National Menopause Foundation (NMF) was founded in 2019 to be a trusted and relatable resource to raise awareness and understanding of menopause through education, activism, and community building. Created for women and by women, the National Menopause Foundation is building an informed community where women can learn, exchange information, find support and be inspired as they approach and journey through Menopause. NMF destigmatizes Menopause by increasing the public awareness, knowledge and positive perception of this phase in women's lives. For more information visit www.nationalmenopausefoundation.org.

Media Contact:
Claire Gill
[email protected]

1 Burkard T, Moser M, Rauch M, Jick SS, Meier CR. Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study. Menopause. 2019 Jul;26(7):741-749. [PubMed] [Reference list]

2 Menopause: The Journal of The North American Menopause Society, Vol. 21, No. 10, pp. 000/000, DOI: 10.1097/gme.0000000000000319, * 2014 by The North American Menopause Society

3 Santoro N, et al. Obstet Gynecol Clin North Am. 2011;38(3):417-423.

SOURCE National Menopause Foundation

These press releases may also interest you

at 21:30
The "Hydroxypropyl Methylcellulose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to  ResearchAndMarkets.com's offering. The latest industry analysis on the Hydroxypropyl Methylcellulose...

at 21:00
The "Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific contrast media agent and injector system market was valued at $1.98...

at 20:50
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000...

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...

News published on and distributed by: